Ancora-SB Overtube for Small Bowel Disease
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you stop taking anticoagulant and antiplatelet medications for the procedure. Other medications are not specifically mentioned, so it's best to discuss with the trial team.
What data supports the effectiveness of the treatment Ancora-SB Overtube for Small Bowel Disease?
Research shows that spiral enteroscopy, a component of the Ancora-SB Overtube treatment, is safe and effective for managing small bowel issues, with favorable diagnostic results compared to other methods. Additionally, double-balloon enteroscopy, another component, is widely accepted for its ability to thoroughly examine and treat the small bowel, improving clinical outcomes.12345
Is the Ancora-SB Overtube for Small Bowel Disease safe for humans?
The Ancora-SB Overtube, similar to other small bowel endoscopy techniques like spiral enteroscopy and push enteroscopy, is generally considered safe for humans. These procedures have been performed thousands of times worldwide with a low risk of complications, making them a reliable option for examining and treating small bowel conditions.12456
What makes the Ancora-SB Overtube treatment for small bowel disease unique?
The Ancora-SB Overtube treatment is unique because it uses a spiral enteroscopy technique, which involves a special over-tube system to help doctors reach deep into the small bowel more effectively than traditional methods. This approach can be easier and more efficient, especially for less experienced operators, compared to other techniques like double-balloon or single-balloon enteroscopy.7891011
What is the purpose of this trial?
Demonstrate superiority of the Aspero Medical Ancora-SB balloon Overtube compared to the Olympus ST-SB1 Balloon Overtube.
Eligibility Criteria
This trial is for adults aged 18-90 with small bowel disease, who can consent and follow study rules. They must be safe for single balloon enteroscopy (ASA Class I-III) and have lesions in the middle third of the small bowel identified by video capsule endoscopy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo enteroscopy using either the Ancora-SB or Olympus ST-SB1 Balloon Overtube to identify lesions in the small intestine
Follow-up
Participants are monitored for safety and effectiveness after the enteroscopy procedure
Treatment Details
Interventions
- Enteroscopy
Enteroscopy is already approved in United States, European Union, Japan for the following indications:
- Diagnosis and treatment of small intestine diseases
- Removal of polyps
- Diagnosis of bleeding areas
- Stretching or widening of strictures
- Collection of foreign bodies
- Biopsy collection
- Diagnosis and treatment of small intestine diseases
- Removal of polyps
- Diagnosis of bleeding areas
- Stretching or widening of strictures
- Collection of foreign bodies
- Biopsy collection
- Diagnosis and treatment of small intestine diseases
- Removal of polyps
- Diagnosis of bleeding areas
- Stretching or widening of strictures
- Collection of foreign bodies
- Biopsy collection
Find a Clinic Near You
Who Is Running the Clinical Trial?
Aspero Medical, Inc.
Lead Sponsor
National Institutes of Health (NIH)
Collaborator